Please create a SOAP note for a 78-year-old male presenting for a Medicare wellness exam, with a chronic non-ruptured abdominal aortic aneurysm (AAA) monitored every three years by abdominal ultrasound and MRI, who had a stool test, reports abdominal bloating and vaping, is due for colonoscopy, and has hypertension, hyperlipidemia, and benign prostatic hyperplasia (BPH), including appropriate CPT and ICD-10 codes and a gastroenterology referral.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

SOAP Note: 78-Year-Old Male Medicare Wellness Exam with Chronic AAA


SUBJECTIVE

Chief Complaint: Follow-up Medicare Annual Wellness Visit

History of Present Illness:

  • 78-year-old male presents for Medicare Annual Wellness Visit
  • Reports abdominal bloating (onset, duration, severity, associated symptoms not specified)
  • Currently vaping (frequency and duration not specified)
  • Known chronic non-ruptured abdominal aortic aneurysm, monitored every 3 years with abdominal ultrasound and MRI
  • Most recent AAA imaging report shows stable aneurysm
  • Due for colonoscopy

Past Medical History:

  • Chronic non-ruptured abdominal aortic aneurysm
  • Hypertension
  • Hyperlipidemia
  • Benign prostatic hyperplasia (BPH)

Social History:

  • Current vaping use (significant risk factor for AAA progression and rupture)
  • Smoking history: unclear if former smoker or only current vaper

Medications: (Not specified - should include antihypertensives, statins)

Allergies: (Not specified)


OBJECTIVE

Vital Signs: (Not provided - should include BP, HR, weight, BMI)

Physical Examination:

  • General: (Not specified)
  • Cardiovascular: (Not specified - should include peripheral pulses, abdominal aortic pulsation assessment)
  • Abdomen: (Not specified - should assess for tenderness, distension related to bloating complaint)
  • Extremities: (Not specified - should assess for peripheral vascular disease)

Cognitive Assessment:

  • SLUMS (Saint Louis University Mental Status) examination performed in office (score not provided)

Recent Imaging:

  • AAA surveillance imaging (ultrasound and MRI) shows stable aneurysm (specific diameter not provided)

ASSESSMENT

Primary Diagnoses:

  1. Chronic non-ruptured abdominal aortic aneurysm, stable (ICD-10: I71.4)

    • Critical management issue: This patient requires more frequent AAA surveillance than every 3 years. Current monitoring interval is inappropriate and potentially dangerous. 1, 2
    • As a 78-year-old male with vaping history (nicotine use), he meets USPSTF Grade B recommendation criteria for AAA screening and requires diameter-based surveillance. 1, 3
    • Surveillance intervals should be: 3.0-3.9 cm every 3 years; 4.0-4.9 cm annually; 5.0-5.4 cm every 6 months 4
    • Vaping represents ongoing nicotine exposure and significantly increases AAA rupture risk - requires aggressive cessation counseling 5
  2. Abdominal bloating, unspecified (ICD-10: R14.0)

    • Requires gastroenterology evaluation to rule out malignancy, inflammatory bowel disease, or other pathology
    • Patient overdue for colonoscopy screening
  3. Nicotine dependence, vaping (ICD-10: F17.290)

    • Absolute contraindication to continue with known AAA - vaping/smoking is the strongest modifiable risk factor for AAA progression and rupture 1, 5
    • Requires immediate cessation intervention
  4. Essential hypertension (ICD-10: I10)

    • Target SBP 120-129 mmHg per 2024 ESC guidelines 2
    • Should include ACE inhibitor or ARB in regimen 2
  5. Hyperlipidemia (ICD-10: E78.5)

    • Target LDL-C <55 mg/dL (<1.4 mmol/L) with >50% reduction from baseline per 2024 ESC guidelines for atherosclerotic PAAD 2
    • Requires statin therapy; add ezetimibe if target not met; consider PCSK9 inhibitor if still not at goal 2
  6. Benign prostatic hyperplasia (ICD-10: N40.0)

  7. Encounter for screening for malignant neoplasm of colon (ICD-10: Z12.11)

    • Overdue for colonoscopy

PLAN

1. Abdominal Aortic Aneurysm Management

Immediate Actions:

  • Obtain exact AAA diameter from most recent imaging report to determine appropriate surveillance interval
  • Correct surveillance protocol:
    • If 3.0-3.9 cm: ultrasound every 3 years
    • If 4.0-4.9 cm: ultrasound annually
    • If 5.0-5.4 cm: ultrasound every 6 months
    • If ≥5.5 cm: refer to vascular surgery for repair consideration 4, 2
  • Discontinue MRI for routine surveillance - ultrasound is the recommended modality for AAA monitoring per USPSTF and ACR guidelines 1, 4
  • Reserve CT angiography for pre-operative planning only if surgical repair becomes indicated 4, 6

Risk Factor Modification:

  • Smoking/vaping cessation is mandatory - Grade A recommendation 2
    • Prescribe combination nicotine replacement therapy + varenicline or bupropion
    • Refer to tobacco cessation program
    • Document that continued vaping significantly increases rupture risk and mortality
  • Blood pressure control: Target SBP 120-129 mmHg 2
    • Ensure ACE inhibitor or ARB in regimen
  • Lipid management: Target LDL-C <55 mg/dL with >50% reduction 2
    • High-intensity statin required
    • Add ezetimibe if not at goal
    • Consider PCSK9 inhibitor if maximally tolerated statin + ezetimibe insufficient

2. Abdominal Bloating

  • Refer to Gastroenterology for evaluation of abdominal bloating and overdue colonoscopy
  • Consider basic workup: CBC, CMP, celiac panel, stool studies if indicated
  • Colonoscopy scheduling per GI recommendations

3. Hypertension

  • Review current antihypertensive regimen (not provided)
  • Ensure includes ACE inhibitor or ARB 2
  • Titrate to achieve SBP 120-129 mmHg
  • Home blood pressure monitoring

4. Hyperlipidemia

  • Check fasting lipid panel
  • Ensure on high-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg) 2
  • Add ezetimibe 10 mg daily if LDL-C not <55 mg/dL
  • Consider PCSK9 inhibitor if target not achieved on statin + ezetimibe

5. Benign Prostatic Hyperplasia

  • Continue current management
  • Assess symptom control

6. Medicare Annual Wellness Visit Components

  • SLUMS cognitive assessment completed (document score)
  • Update advance directives
  • Review preventive services
  • Medication reconciliation
  • Fall risk assessment
  • Depression screening (PHQ-2/PHQ-9)
  • Functional status assessment

7. Patient Education

  • Extensive counseling on AAA rupture risk with continued vaping - emphasize mortality risk
  • Mediterranean diet for cardiovascular disease prevention 2
  • Regular low-to-moderate intensity aerobic activity as tolerated 2
  • Importance of blood pressure and lipid control
  • Warning signs of AAA rupture: sudden severe abdominal/back pain, syncope - call 911 immediately

ORDERS/REFERRALS

Laboratory:

  • Fasting lipid panel
  • Basic metabolic panel
  • HbA1c (if not recently checked)
  • CBC

Imaging:

  • Review exact diameter from most recent AAA imaging
  • Schedule next AAA ultrasound based on diameter (see surveillance intervals above)

Referrals:

  • Gastroenterology - for abdominal bloating evaluation and colonoscopy
  • Tobacco cessation program - urgent
  • Consider vascular surgery consultation if AAA ≥5.0 cm for discussion of repair timing

Prescriptions:

  • Nicotine replacement therapy (patch + gum/lozenge)
  • Varenicline 0.5 mg daily x3 days, then 0.5 mg BID x4 days, then 1 mg BID x11 weeks (or bupropion alternative)
  • Optimize antihypertensive regimen (specific medications depend on current regimen)
  • Optimize statin ± ezetimibe based on lipid panel results

CPT CODES

  • G0438 - Annual wellness visit; includes a personalized prevention plan of service (PPPS), initial visit (if first AWV)
    • OR G0439 - Annual wellness visit; includes a personalized prevention plan of service (PPPS), subsequent visit (if not first AWV)
  • 96127 - Brief emotional/behavioral assessment (depression screening)
  • 99497 - Advance care planning (if >30 minutes spent on this)

ICD-10 CODES

Primary:

  • I71.4 - Abdominal aortic aneurysm, without rupture

Secondary:

  • R14.0 - Abdominal distension (bloating)
  • F17.290 - Nicotine dependence, unspecified, uncomplicated (vaping)
  • I10 - Essential (primary) hypertension
  • E78.5 - Hyperlipidemia, unspecified
  • N40.0 - Benign prostatic hyperplasia without lower urinary tract symptoms
  • Z12.11 - Encounter for screening for malignant neoplasm of colon
  • Z00.00 - Encounter for general adult medical examination without abnormal findings (or Z00.01 if abnormal findings)
  • Z13.89 - Encounter for screening for other disorder (for AAA surveillance)

FOLLOW-UP

  • Return in 2-4 weeks to review laboratory results and assess tobacco cessation progress
  • GI appointment as scheduled
  • AAA ultrasound per diameter-based surveillance protocol
  • Blood pressure recheck in 2-4 weeks if medication adjustments made

Critical safety note: The current 3-year surveillance interval for this patient's AAA is potentially dangerous and must be corrected immediately based on actual aneurysm diameter. Continued vaping with known AAA represents a life-threatening combination requiring urgent intervention. 1, 2, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.